Next Article in Journal
The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom
Next Article in Special Issue
An Antigenic Thrift-Based Approach to Influenza Vaccine Design
Previous Article in Journal
The Many Faces of Innate Immunity in SARS-CoV-2 Infection
Previous Article in Special Issue
Introduction of Cysteines in the Stalk Domain of Recombinant Influenza Virus N1 Neuraminidase Enhances Protein Stability and Immunogenicity in Mice
 
 
Review

Article Versions Notes

Vaccines 2021, 9(6), 597; https://doi.org/10.3390/vaccines9060597
Action Date Notes Link
article html file updated 25 December 2025 13:19 CET Update https://www.mdpi.com/2076-393X/9/6/597/html
article html file updated 2 September 2025 09:53 CEST Update -
article html file updated 22 August 2025 01:02 CEST Update -
article html file updated 26 July 2022 22:50 CEST Update -
article html file updated 4 June 2021 10:49 CEST Original file -
article pdf uploaded. 4 June 2021 10:48 CEST Version of Record https://www.mdpi.com/2076-393X/9/6/597/pdf
article xml uploaded. 4 June 2021 10:48 CEST Update https://www.mdpi.com/2076-393X/9/6/597/xml
article xml file uploaded 4 June 2021 10:48 CEST Original file -
Back to TopTop